Lv1
40 积分 2024-01-09 加入
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapies
2个月前
已完结
Expanding the human proteome with microproteins and peptideins
3个月前
已完结
Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma
5个月前
已完结
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study
6个月前
已完结
皖公网安备34019202002308
